References
- Notelovitz M, Levenson I, McKenzie L, Lane D, Kitchen C. The effect of low-dose oral contraceptives on coagulation and fibrinolysis in two high risk populations: young female smokers and older premenopausal women. Am J Obstet Gynecol 1985; 152: 995–1000
- Realini G J, Goldzieher J W. Oral contraceptives and cardiovascular disease: a critique of epidemiologic studies. Am J Obstet Gynecol 1985; 152: 729–98
- Effect on hypertension and benign breast disease of progestogen component in combined oral contraceptives. Royal College of General Practitioners' Oral Contraceptive Study. Lancet 1977; i: 624
- Stadel B V. Oral contraceptives and arterial disease. Oral Contraceptives and Lipoproteins, P A van Keep, H Kopera. International Health Foundation, Geneva 1983; 30–43
- Frank P. Progestogens, lipoproteins, and arterial disease. Evidence from the study of the Royal College of General Practitioners. Oral Contraceptives and Lipoproteins, P A van Keep, H Kopera. International Health Foundation, Geneva 1983; 44–51
- Steel J M, Duncan L JP. Contraception for insulin-dependent diabetic women: The view from one clinic. Diabetes Care 1980; 3: 557–60
- Lydecken K. Therapeutic amenorrhea induced with lynestrenol in mentally retarded. Acta Psychiatr Scand (SUPPI) 1972; 229: 7–67
- Roding S. Influence of Orgametril-induced amenorrhea on the emotional condition and aggressivity in women and girls with mental retardation. Med Monatschr 1976; 30: 415–21
- Mazaheri A, Fotherby A, Chapman J R. Metabolism of lynestrenol to norethisterone in liver homogenate. J Endocrin 1970; 47: 251–2
- Linden V. Myocardial infarction in epileptics. Brit Med J 1975; ii: 87
- Livingstone S. Phenytoin and serum cholesterol. Brit Med J 1976; i: 586
- Muuronen A, Kaste M, Nikkilä E A, Tolppanen E-M. Mortality from ischemic heart disease among patients using anticonvulsive drugs: a case-control study. Brit Med J 1985; 291: 1481–3
- Kay C. Present perspectives and clinical implications. In: The pill in perspective. J Obstet Gynecol 1984; 4: 98–102